U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
OLATHE, Kan., March 01, 2016 -- Innara Health today announced that a multi-center randomized control trial (RCT) has shown that premature infants who received treatment with the NTrainer System® demonstrated improved transition to independent oral feeding. The improvements led to reduced use of feeding tubes and a reduction in length of stay (LOS) in the neonatal intensive care unit (NICU). Dr. Dongli Song, the principal investigator of the trial at Santa Clara Valley Medical Center in San Jose, California, received notification that the Pediatric Academic Societies (PAS) group has accepted two abstracts for poster presentation at the annual meeting.
“We are excited to have the opportunity to present our study at PAS. Achieving independent oral feeding represents an essential developmental milestone for premature infants. We need innovative therapies to improve their feeding readiness,” said Dr. Song. “I hope our presentation at this international conference will bring greater attention to this important issue.”
“This is an exciting development that will help the neonatal community better understand the developmental needs and capabilities of the premature infant,” said Michael Peck, CEO of Innara Health. “The reduced requirement for tube feeding, supported by the trial, could result in improved patient safety and reduced healthcare costs, as well as help these infants get home to their families sooner.”
The poster presentation of the trial will demonstrate objective data from 189 patients in a randomized control trial conducted at Santa Clara Valley Medical Center in San Jose, California; Children's Hospital at Montefiore-Weiler Division, Albert Einstein College of Medicine in Bronx, New York; Cook Children's Medical Center in Fort Worth, Texas; Children's Hospital at Montefiore-Wakefield Division, Albert Einstein College of Medicine in Bronx, New York; and North Central Baptist Hospital in San Antonio, Texas. The two poster sessions are scheduled to be presented at PAS in late April 2016.
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
Contact Wendy Slatery Telephone 913-742-4456 E-mail [email protected]
